Credit: Sergey Nivens/Shutterstock.com

The median annual price of 13 new drugs approved this year by the U.S. Food and Drug Administration for chronic conditions is $257,000, according to a new analysis from Reuters. Additionally, seven other recently launched drugs are priced at more than $200,000 per year. By comparison, the median annual price for the first 30 drugs marketed through mid-July 2021 was $180,000, according to a Journal of the American Medical Association study.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Core and Group Health
Health Care Reform
C-Suite
Employee-Paid
Employer-Paid